Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor.

Kowalchuk, Roman O; Waters, Michael R; Baliga, Sujith; Richardson, K Martin; Spencer, Kelly M; Larner, James M; Kersh, Charles R

Kowalchuk, Roman O; Waters, Michael R; Baliga, Sujith; Richardson, K Martin; Spencer, Kelly M; Larner, James M; Kersh, Charles R.

Afiliação

Kowalchuk RO; University of Virginia/Riverside, Radiosurgery Center, Newport News, VA, USA.
Waters MR; University of Virginia/Riverside, Radiosurgery Center, Newport News, VA, USA.
Baliga S; Department of Radiation Oncology, The Ohio State University, Columbus, OH, USA.
Richardson KM; University of Virginia/Riverside, Radiosurgery Center, Newport News, VA, USA.
Spencer KM; University of Virginia/Riverside, Radiosurgery Center, Newport News, VA, USA.
Larner JM; Department of Radiation Oncology, University of Virginia, Charlottesville, VA, USA.
Kersh CR; University of Virginia/Riverside, Radiosurgery Center, Newport News, VA, USA.

Transl Lung Cancer Res ; 9(5): 1862-1872, 2020 Oct.

Article em En | MEDLINE | ID: mdl-33209608

Palavras-chave

Lung neoplasms; non-small cell lung; patient selection; radiosurgery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article